Badros, A. Z., Ma, N., Rapoport, A. P., Lederer, E., & Lesokhin, A. M. (2019). Long-term remissions after stopping pembrolizumab for relapsed or refractory multiple myeloma. Blood Adv.
Stile di citazione ChicagoBadros, Ashraf Z., Ning Ma, Aaron P. Rapoport, Emily Lederer, e Alexander M. Lesokhin. "Long-term Remissions After Stopping Pembrolizumab for Relapsed or Refractory Multiple Myeloma." Blood Adv 2019.
Citazione MLABadros, Ashraf Z., et al. "Long-term Remissions After Stopping Pembrolizumab for Relapsed or Refractory Multiple Myeloma." Blood Adv 2019.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.